Condition
Complex Regional Pain Syndrome Type II
Total Trials
5
Recruiting
0
Active
0
Completed
2
Success Rate
66.7%-20% vs avg
Key Insights
Highlights
Success Rate
67% trial completion
Clinical Risk Assessment
Based on trial outcomes
Moderate Risk
Score: 37/100
Termination Rate
20.0%
1 terminated out of 5 trials
Success Rate
66.7%
-19.8% vs benchmark
Late-Stage Pipeline
20%
1 trials in Phase 3/4
Results Transparency
100%
2 of 2 completed with results
Key Signals
2 with results67% success
Data Visualizations
Phase Distribution
4Total
Not Applicable (2)
P 2 (1)
P 4 (1)
Trial Status
Completed2
Withdrawn1
Enrolling By Invitation1
Terminated1
Trial Success Rate
66.7%
Benchmark: 86.5%
Based on 2 completed trials
Clinical Trials (5)
Showing 5 of 5 trials
NCT06306157Phase 4Enrolling By Invitation
Low Dose Naltrexone Therapy for Complex Regional Pain Syndrome
NCT05160038Not ApplicableCompleted
Embodied Virtual Reality for Chronic Pain
NCT00815932Not ApplicableWithdrawn
The Effect of Transcranial Direct Current Stimulation (t-DCS) On the P300 Component of Event-Related Potentials in Patients With Chronic Neuropathic Pain Due To CRPS or Diabetic Neuropathy
NCT00006289Phase 2Terminated
Neurotropin to Treat Chronic Neuropathic Pain
NCT00431847Completed
Regional Anesthesia Military Battlefield Pain Outcomes Study
Showing all 5 trials